- Home
- XCUR vs RPTX Comparison
XCUR vs RPTX Comparison
Compare XCUR & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XCUR
- RPTX
- Stock Information
- Founded
- XCUR 2011
- RPTX 2016
- Country
- XCUR United States
- RPTX Canada
- Employees
- XCUR N/A
- RPTX N/A
- Industry
- XCUR Biotechnology: Pharmaceutical Preparations
- RPTX Biotechnology: Pharmaceutical Preparations
- Sector
- XCUR Health Care
- RPTX Health Care
- Exchange
- XCUR Nasdaq
- RPTX Nasdaq
- Market Cap
- XCUR 59.0M
- RPTX 63.9M
- IPO Year
- XCUR N/A
- RPTX 2020
- Fundamental
- Price
- XCUR $7.86
- RPTX $1.41
- Analyst Decision
- XCUR
- RPTX Strong Buy
- Analyst Count
- XCUR 0
- RPTX 3
- Target Price
- XCUR N/A
- RPTX $4.50
- AVG Volume (30 Days)
- XCUR 5.7K
- RPTX 94.4K
- Earning Date
- XCUR 08-12-2025
- RPTX 08-05-2025
- Dividend Yield
- XCUR N/A
- RPTX N/A
- EPS Growth
- XCUR N/A
- RPTX N/A
- EPS
- XCUR N/A
- RPTX N/A
- Revenue
- XCUR $500,000.00
- RPTX $1,073,000.00
- Revenue This Year
- XCUR N/A
- RPTX N/A
- Revenue Next Year
- XCUR N/A
- RPTX N/A
- P/E Ratio
- XCUR N/A
- RPTX N/A
- Revenue Growth
- XCUR N/A
- RPTX N/A
- 52 Week Low
- XCUR $1.44
- RPTX $0.89
- 52 Week High
- XCUR $36.00
- RPTX $4.29
- Technical
- Relative Strength Index (RSI)
- XCUR 31.28
- RPTX 51.83
- Support Level
- XCUR $7.53
- RPTX $1.33
- Resistance Level
- XCUR $8.96
- RPTX $1.48
- Average True Range (ATR)
- XCUR 0.69
- RPTX 0.05
- MACD
- XCUR -0.20
- RPTX -0.01
- Stochastic Oscillator
- XCUR 6.42
- RPTX 34.37
About XCUR Exicure Inc.
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.